currency of the future, Reviews

The action plan can be called a heavy release in Shanghai, and I will simply classify the main contents.Just when everyone was still sick, A-shares ushered in good news. Shanghai issued the "Shanghai Action Plan to Support the Merger and Reorganization of Listed Companies (2025-2027)". Is this to retain injured retail investors? Next, let's discuss it in detail.It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.

Just when everyone was still sick, A-shares ushered in good news. Shanghai issued the "Shanghai Action Plan to Support the Merger and Reorganization of Listed Companies (2025-2027)". Is this to retain injured retail investors? Next, let's discuss it in detail.In the end, the A-share market has ushered in a positive trend. However, investors were like frightened birds after Tuesday's A-share surge and fall. They were already afraid of good news and didn't know whether to leave or stay. Personally, as long as the trend of A shares does not go bad, I will choose to stay.On Tuesday, A-shares opened sharply higher and fell back, and walked out of the disgusting market, which was worse than stepping on the air. The highest point in the market was close to 3,500 points, and the result closed at 3,422.66.

Fourth, the lowest point of the market index on Tuesday was 3417.77, closing at 3422.66, which means "smooth and profitable".Fourth, other fields also involve industrial chains such as electronic information generation, a new generation of intelligent networked vehicles and new energy vehicles, and also mention accelerating the merger of securities companies.Second, the key areas mainly involve integrated circuits, biomedicine, new materials and other industries. Make good use of the 10 billion yuan integrated circuit design industry M&A fund and set up a 10 billion yuan biomedical industry M&A fund;